CALYM and EMBLEEMA sign a strategic partnership to deploy next-generation clinical research solutions for life sciences.
« Patients are at the center of all medical research projects. Transparency, security, and data accessibility are major concerns. It is a privilege to partner with Embleema to build the next generation of a patient-centered trust network with all stakeholders involved in our research programs. »
« We are delighted to partner with CALYM and its world-class clinical research network in the field of lymphoma. By combining our capabilities, we will be able to accelerate R&D and bring new remedies to lymphoma patients more quickly. »